AI Summary

An international study found that 60% of patients with early severe systemic sclerosis remained progression‑free ten years after receiving autologous bone‑marrow transplantation. The results add evidence that the procedure provides sustained clinical benefits and long‑term safety for this rare, heterogeneous autoimmune disease, which is marked by progressive skin and organ fibrosis and carries high morbidity and mortality in its severe forms.

AI summaries can be wrong sometimes—always verify important details using the source article.